ADMA Biologics, Inc.
ADMA
$8.41
$0.536.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 138.15M | 87.63M | 61.39M | 90.29M | 71.63M |
| Total Receivables | 135.86M | 158.43M | 137.67M | 109.73M | 99.41M |
| Inventory | 222.10M | 206.47M | 196.67M | 191.46M | 172.19M |
| Prepaid Expenses | 15.06M | 7.46M | 6.93M | 8.09M | 8.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 6.53M | -- | -- | -- |
| Total Current Assets | 511.17M | 466.51M | 402.66M | 399.56M | 351.81M |
|
|
|||||
| Total Current Assets | 511.17M | 466.51M | 402.66M | 399.56M | 351.81M |
| Net Property, Plant & Equipment | 71.41M | 71.71M | 78.78M | 66.46M | 65.73M |
| Long-term Investments | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Goodwill | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Total Other Intangibles | 630.00K | 632.00K | 491.00K | 527.00K | 452.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 78.44M | 81.86M | 83.23M | 88.30M | 89.04M |
| Total Assets | 665.18M | 624.24M | 568.69M | 558.38M | 510.57M |
|
|
|||||
| Total Accounts Payable | 20.52M | 22.52M | 24.02M | 29.77M | 20.61M |
| Total Accrued Expenses | 28.09M | 27.68M | 23.48M | 23.71M | 22.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.46M | 3.91M | 3.64M | 1.13M | 1.19M |
| Total Finance Division Other Current Liabilities | 20.48M | 15.43M | 5.35M | 20.33M | 8.79M |
| Total Other Current Liabilities | 20.48M | 15.43M | 5.35M | 20.33M | 8.79M |
| Total Current Liabilities | 73.54M | 69.54M | 56.49M | 74.94M | 53.50M |
|
|
|||||
| Total Current Liabilities | 73.54M | 69.54M | 56.49M | 74.94M | 53.50M |
| Long-Term Debt | 193.58M | 69.33M | 70.08M | 73.40M | 72.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.37M | 6.65M | 9.40M | 9.30M | 8.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.37M | 1.41M | 1.53M | 2.42M | 2.83M |
| Total Liabilities | 274.86M | 146.92M | 137.50M | 160.06M | 137.15M |
|
|
|||||
| Common Stock & APIC | 649.82M | 671.06M | 665.41M | 660.93M | 655.10M |
| Retained Earnings | -116.33M | -161.65M | -211.03M | -247.46M | -281.68M |
| Treasury Stock & Other | -143.17M | -32.09M | -23.19M | -15.15M | -- |
| Total Common Equity | 390.33M | 477.32M | 431.19M | 398.33M | 373.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 390.33M | 477.32M | 431.19M | 398.33M | 373.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 390.33M | 477.32M | 431.19M | 398.33M | 373.42M |
|
|
|||||